P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response.
Authors | |
---|---|
Year of publication | 2023 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Description | Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response - EHA 2023 in HemaSphere (2023) conference abstract. |
Related projects: |